Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Fisher

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Molecular Ecology Resources|September 17, 2013
HeFPipe: a complete analytical pipeline for heterozygosity-fitness correlation studiesMark A Fisher
Journal of Clinical Microbiology|January 13, 2017
Antimicrobial Susceptibility Patterns among a Large, Nationwide Cohort of Abiotrophia and Granulicatella Clinical IsolatesKunatum Prasidthrathsint, Mark A Fisher
International Journal of Systematic and Evolutionary Microbiology|March 7, 2020
Characterization of six clinical isolates of <i>Chimaeribacter</i> gen. nov., a novel genus related to the <i>Yersiniaceae</i> family and the three species <i>Chimaeribacter arupi</i> sp. nov., <i>Chimaeribacter coloradensis</i> sp. nov<i>,</i> and <i>Chimaeribacter californicus</i> sp. novAlessandro Rossi, Mark A Fisher
Journal of Clinical Microbiology|August 30, 2013
Novel approach for differentiating Shigella species and Escherichia coli by matrix-assisted laser desorption ionization-time of flight mass spectrometryPrasanna D Khot, Mark A Fisher
Antimicrobial Agents and Chemotherapy|November 20, 2013
Susceptibility profiles of Nocardia isolates based on current taxonomyRobert Schlaberg, Mark A Fisher, Kimberley E Hanson
Biorxiv : the Preprint Server for Biology|March 12, 2024
Antibacterial activity of <i>Xenopsylla cheopis</i> attacins against <i>Yersinia pestis</i>Basil Mathew, Kari L Aoyagi, Mark A Fisher
Emerging Infectious Diseases|March 2, 2012
A systematic approach for discovering novel, clinically relevant bacteriaRobert Schlaberg, Keith E Simmon, Mark A Fisher
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 24, 2024
Re: "HANCEK" infective endocarditis: a case for including Neisseria elongata in the HACEK groupBrandon J Webb, Mark A Fisher, Nick Tinker
ACS Infectious Diseases|July 28, 2021
<i>Yersinia pestis</i> Lipopolysaccharide Remodeling Confers Resistance to a <i>Xenopsylla cheopis</i> CecropinBasil Mathew, Kari L Aoyagi, Mark A Fisher
Biorxiv : the Preprint Server for Biology|September 4, 2023
Enterobacterial common antigen biosynthesis in <i>Yersinia pestis</i> is tied to antimicrobial peptide resistanceKari L Aoyagi, Basil Mathew, Mark A Fisher
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Molecular Ecology Resources|September 17, 2013
HeFPipe: a complete analytical pipeline for heterozygosity-fitness correlation studiesMark A Fisher
Journal of Clinical Microbiology|January 13, 2017
Antimicrobial Susceptibility Patterns among a Large, Nationwide Cohort of Abiotrophia and Granulicatella Clinical IsolatesKunatum Prasidthrathsint, Mark A Fisher
International Journal of Systematic and Evolutionary Microbiology|March 7, 2020
Characterization of six clinical isolates of <i>Chimaeribacter</i> gen. nov., a novel genus related to the <i>Yersiniaceae</i> family and the three species <i>Chimaeribacter arupi</i> sp. nov., <i>Chimaeribacter coloradensis</i> sp. nov<i>,</i> and <i>Chimaeribacter californicus</i> sp. novAlessandro Rossi, Mark A Fisher
Journal of Clinical Microbiology|August 30, 2013
Novel approach for differentiating Shigella species and Escherichia coli by matrix-assisted laser desorption ionization-time of flight mass spectrometryPrasanna D Khot, Mark A Fisher
Antimicrobial Agents and Chemotherapy|November 20, 2013
Susceptibility profiles of Nocardia isolates based on current taxonomyRobert Schlaberg, Mark A Fisher, Kimberley E Hanson
Biorxiv : the Preprint Server for Biology|March 12, 2024
Antibacterial activity of <i>Xenopsylla cheopis</i> attacins against <i>Yersinia pestis</i>Basil Mathew, Kari L Aoyagi, Mark A Fisher
Emerging Infectious Diseases|March 2, 2012
A systematic approach for discovering novel, clinically relevant bacteriaRobert Schlaberg, Keith E Simmon, Mark A Fisher
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 24, 2024
Re: "HANCEK" infective endocarditis: a case for including Neisseria elongata in the HACEK groupBrandon J Webb, Mark A Fisher, Nick Tinker
ACS Infectious Diseases|July 28, 2021
<i>Yersinia pestis</i> Lipopolysaccharide Remodeling Confers Resistance to a <i>Xenopsylla cheopis</i> CecropinBasil Mathew, Kari L Aoyagi, Mark A Fisher
Biorxiv : the Preprint Server for Biology|September 4, 2023
Enterobacterial common antigen biosynthesis in <i>Yersinia pestis</i> is tied to antimicrobial peptide resistanceKari L Aoyagi, Basil Mathew, Mark A Fisher
Pageof 6